The Soltive Laser System, which uses thulium fiber laser technology, has been shown to generate finer particulate and dusted stones in half the time as a standard holmium yttrium aluminium garnet laser.
In this Urology Times® podcast, Rana McKay, MD, discusses a study utilizing Medicare claims data from more than 6,000 mCRPC patients who had been treated with immunotherapy, oral medications, or both. She highlights key findings, including reduced risk of death and extended median overall survival. Listen to the podcast.
Want the latest in urology, but no time to read? Check out our new podcast, “Speaking of Urology” to get expert clinical analysis, practice advice, and policy perspectives, all in a convenient virtual format.Listen now!
